Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes
about
Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancer.Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
P2860
Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@ast
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@en
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@nl
type
label
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@ast
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@en
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@nl
prefLabel
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@ast
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@en
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@nl
P2093
P2860
P356
P1476
Breakthrough therapy for perit ...... neal chemotherapy with taxanes
@en
P2093
Eiji Sunami
Hiroaki Nozawa
Hironori Ishigami
Hironori Yamaguchi
Joji Kitayama
Junichiro Tanaka
Kazushige Kawai
Keisuke Hata
Kensuke Otani
Koji Yasuda
P2860
P304
P356
10.4251/WJGO.V7.I11.285
P407
P577
2015-11-15T00:00:00Z